Personalized Treatment Options for Brain Cancer
Personalized treatment planning and innovative immunotherapy approaches for patients with brain tumors.
Request a Case Review
Personalized Treatment Options for Brain Cancer
Personalized treatment planning and innovative immunotherapy approaches for patients with brain tumors.
Request a Case Review
A brain cancer diagnosis can be overwhelming, especially when treatment options appear limited. Patients with glioblastoma, astrocytoma, and other aggressive brain tumors often seek additional treatment options after surgery, radiotherapy, or chemotherapy.
Biotherapy International provides individualized case reviews and information about personalized immunotherapy approaches for patients with glioblastoma, astrocytoma, and other brain tumors.
Biotherapy International provides individualized case reviews and information about personalized immunotherapy approaches for patients with glioblastoma, astrocytoma, and other brain tumors.
A brain cancer diagnosis can be overwhelming, especially when treatment options appear limited. Patients with glioblastoma, astrocytoma, and other aggressive brain tumors often seek additional treatment options after surgery, radiotherapy, or chemotherapy.
Biotherapy International provides individualized case reviews and information about personalized immunotherapy approaches for patients with glioblastoma, astrocytoma, and other brain tumors.
Biotherapy International provides individualized case reviews and information about personalized immunotherapy approaches for patients with glioblastoma, astrocytoma, and other brain tumors.
I accept the terms of the Privacy Policy and agree to the processing of my personal information
Request a Case Review
Just type your contacts and message
How can we help?
Send us a message
Follow Up Call
Enter your details to receive a call back from us
Innovative Immunotherapy Approaches for Brain Tumors
1
Oncolytic Viruses are human-safe viruses with specific receptors that can penetrate and destroy cancer cells. They also increase the recognition of the tumor by the patient's own immune system.
3
Intratumoral Injections:
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
All methods are based on sound scientific data, and confirmed through extensive clinical trials involving the successful treatment of thousands of patients.
2
Personalized Cancer vaccines are made from the patient's cancer cells. Vaccines train the patient's immune system to recognize and destroy malignant cells, just as it does against infectious agents.
4
Allogeneic Targeted Activated Cancer Killer cells (ATACK) are donor killer cells that selectively destroy tumor tissue. ATACKs are powerful and targeted, so they work even when other methods are ineffective.
Innovative Immunotherapy Approaches for Brain Tumors
1
Oncolytic Viruses are human-safe viruses with specific receptors that can penetrate and destroy cancer cells. They also increase the recognition of the tumor by the patient's own immune system.
3
Intratumoral Injections:
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
applying vaccines directly into the tumor by injection, either immediately after brain tumor removal surgery or via an Ommaya reservoir.
All methods are based on sound scientific data, and confirmed through extensive clinical trials involving the successful treatment of thousands of patients.
2
Personalized Cancer Vaccines are made from the patient's cancer cells. Vaccines train the patient's immune system to recognize and destroy malignant cells, just as it does against infectious agents.
4
Allogeneic Targeted Activated Cancer Killer cells (ATACK) are donor killer cells that selectively destroy tumor tissue. ATACKs are powerful and targeted, so they work even when other methods are ineffective.
Netta’s Story: A Second Chance at Life
Netta, a mother of two, was the first patient in the world to be cured from a highly aggressive type of glioma by combining oncolytic viruses and immunotherapy. She was initially diagnosed in 2010 with anaplastic astrocytoma.
Netta then underwent emergency brain surgery, followed by radiation therapy and a long course of conventional chemotherapy. However, in 2015, the tumour returned.
Her doctors originally recommended a second brain surgery, which could leave her with a severe disability. She refused to take the risk and turned to Biotherapy International, where she got a combination of oncolytic virus and a personalized immunotherapy protocol. As of today, Netta remains cancer-free; her MRIs show no evidence of tumors, and she enjoys a fully active, healthy life.
Netta’s Story: A Second Chance at Life
Netta, a mother of two, was the first patient in the world to be cured from a highly aggressive type of glioma by combining oncolytic viruses and immunotherapy. She was initially diagnosed in 2010 with anaplastic astrocytoma.
Netta then underwent emergency brain surgery, followed by radiation therapy and a long course of conventional chemotherapy. However, in 2015, the tumour returned.
Her doctors originally recommended a second brain surgery, which could leave her with a severe disability. She refused to take the risk and turned to Biotherapy International, where she got a combination of oncolytic virus and a personalized immunotherapy protocol. As of today, Netta remains cancer-free; her MRIs show no evidence of tumors, and she enjoys a fully active, healthy life.
Prof. Shimon Slavin is an internationally recognized pioneer in cancer immunotherapy and cellular therapy. The protocols he has developed are designed to support anti-tumor immune responses and explore innovative approaches beyond conventional treatment options.
Throughout his career, he has published more than 680 scientific articles and four books and has reviewed thousands of patient cases from around the world.
Throughout his career, he has published more than 680 scientific articles and four books and has reviewed thousands of patient cases from around the world.
About Professor Shimon Slavin
Medical & Scientific Director of Biotherapy International
We help patients explore additional treatment options beyond standard therapies.
Prof. Shimon Slavin is an internationally recognized pioneer in cancer immunotherapy and cellular therapy. The protocols he has developed are designed to support anti-tumor immune responses and explore innovative approaches beyond conventional treatment options.
Throughout his career, he has published more than 680 scientific articles and four books and has reviewed thousands of patient cases from around the world.
Throughout his career, he has published more than 680 scientific articles and four books and has reviewed thousands of patient cases from around the world.
About Professor Shimon Slavin
Medical & Scientific Director of Biotherapy International
We help patients explore additional treatment options beyond standard therapies.
Frequently Asked Questions
The potential role of immunotherapy depends on the diagnosis, previous treatments, and the patient's current clinical condition. While no treatment can guarantee a cure, some patients may wish to explore additional options beyond standard therapies. Each case requires an individual medical review.
Yes. Many patients contact us after surgery, radiotherapy, or chemotherapy. Previous treatment does not automatically exclude a patient from being considered for additional immunotherapy approaches. Each case is reviewed individually based on the diagnosis, treatment history, and current clinical condition.
We review cases involving glioblastoma, astrocytoma, DIPG, aggressive gliomas, and other primary brain tumors. Depending on the individual situation, we may discuss personalized immunotherapy approaches that could be relevant for the patient.
To understand whether our approach may be relevant for your individual case, we first need information about your diagnosis, medical history, and previous treatments. Please contact us using the form below to request an individual case review.
Frequently Asked Questions
The potential role of immunotherapy depends on the diagnosis, previous treatments, and the patient's current clinical condition. While no treatment can guarantee a cure, some patients may wish to explore additional options beyond standard therapies. Each case requires an individual medical review.
Yes. Many patients contact us after surgery, radiotherapy, or chemotherapy. Previous treatment does not automatically exclude a patient from being considered for additional immunotherapy approaches. Each case is reviewed individually based on the diagnosis, treatment history, and current clinical condition.
We review cases involving glioblastoma, astrocytoma, DIPG, aggressive gliomas, and other primary brain tumors. Depending on the individual situation, we may discuss personalized immunotherapy approaches that could be relevant for the patient.
We review cases involving glioblastoma, astrocytoma, DIPG, aggressive gliomas, and other primary brain tumors. Depending on the individual situation, we may discuss personalized immunotherapy approaches that could be relevant for the patient.
To understand whether our approach may be relevant for your individual case, we first need information about your diagnosis, medical history, and previous treatments. Please contact us using the form below to request an individual case review.
Explore Your Options
Your journey to recovery begins with the first step
Therese-Herzog-Weg 1, 79618 Rheinfelden , Germany
Our contacts
© 2026 Biotherapy International, All Rights Reserved. Any use of this site constitutes your agreement to the Privacy Policy
The Center for Innovative Cancer Immunotherapy & Cellular Therapy
Biotherapy International
Explore Your Options
Your journey to recovery begins with the first step
© 2026 Biotherapy International, All Rights Reserved. Any use of this site constitutes your agreement to the Privacy Policy
The Center for Innovative Cancer Immunotherapy & Cellular Therapy
Biotherapy International
